Sign In
Buy HZNP
$116.30
+0 (+0%)
At Close: Jan 04, 2024
Horizon Therapeutics shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.
12:00am, Wednesday, 06'th May 2020Hanger (HNGR) to Report Q1 Earnings: What's in the Cards?
12:00am, Tuesday, 05'th May 2020The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Horizon Therapeutics PLC Expected to Post Q1 2020 Earnings of $0.26 Per Share (NASDAQ:HZNP)
05:14am, Friday, 01'st May 2020
Horizon Therapeutics PLC (NASDAQ:HZNP) – Analysts at Jefferies Financial Group issued their Q1 2020 earnings per share (EPS) estimates for shares of Horizon Therapeutics in a research note issued to
CAPROCK Group Inc. Sells 367 Shares of Horizon Therapeutics PLC (NASDAQ:HZNP)
10:12am, Thursday, 30'th Apr 2020
CAPROCK Group Inc. reduced its stake in Horizon Therapeutics PLC (NASDAQ:HZNP) by 3.3% during the first quarter, HoldingsChannel.com reports. The firm owned 10,794 shares of the biopharmaceutical comp
16,300 Shares in Horizon Therapeutics PLC (NASDAQ:HZNP) Acquired by ARP Americas LP
08:36am, Thursday, 30'th Apr 2020
ARP Americas LP bought a new position in Horizon Therapeutics PLC (NASDAQ:HZNP) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 16,300
Horizon Therapeutics Plc (HZNP) EVP, Chief Commercial Officer Vikram Karnani Sold $–. ...
12:00am, Thursday, 30'th Apr 2020Horizon Therapeutics (HZNP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04:34pm, Wednesday, 29'th Apr 2020
Horizon Therapeutics (HZNP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Horizon Therapeutics (HZNP) Set to Announce Quarterly Earnings on Wednesday
09:36am, Wednesday, 29'th Apr 2020
Horizon Therapeutics (NASDAQ:HZNP) will release its earnings data before the market opens on Wednesday, May 6th. Analysts expect Horizon Therapeutics to post earnings of $0.22 per share for the quarte
Jefferies Maintains Buy on Horizon Therapeutics, Raises Price Target to $51
12:00am, Tuesday, 28'th Apr 2020BRIEF-Horizon Therapeutics PLC Announces Availability Of PROCYSBI
12:18pm, Monday, 27'th Apr 2020
Horizon Therapeutics PLC:
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that PROCYSBI® (cysteamine bitartrate) delayed-release oral granules in packets are now available in the United States and can be ordered in 75
Horizon Therapeutics Announces Availability Of PROCYSBI Delayed-Release Oral Granules In Packets In The United States
12:00am, Monday, 27'th Apr 2020Irina Konstantinovsky Sells 19,886 Shares of Horizon Therapeutics PLC (NASDAQ:HZNP) Stock
08:28am, Thursday, 23'rd Apr 2020
Horizon Therapeutics PLC (NASDAQ:HZNP) EVP Irina Konstantinovsky sold 19,886 shares of the business’s stock in a transaction on Monday, April 20th. The stock was sold at an average price of $34.13,
Congress Asset Management Co. MA Cuts Holdings in Horizon Therapeutics PLC (NASDAQ:HZNP)
10:54am, Wednesday, 22'nd Apr 2020
Congress Asset Management Co. MA decreased its stake in shares of Horizon Therapeutics PLC (NASDAQ:HZNP) by 6.7% during the 1st quarter, according to the company in its most recent filing with the Sec
